These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3987021)

  • 61. Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors.
    Donders G; Bellen G; Neven P; Grob P; Prasauskas V; Buchholz S; Ortmann O
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2023-8. PubMed ID: 26223323
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plantar keratoderma climatericum: Successful improvement with a topical estriol cream.
    Mendes-Bastos P
    J Cosmet Dermatol; 2018 Oct; 17(5):811-813. PubMed ID: 28929614
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of desogestrel for hormone replacement therapy on the blood lipid profiles of postmenopausal women.
    Tadmor OP; Kleinman Y; Goldstein R; Diamant YZ
    Int J Gynaecol Obstet; 1992 Oct; 39(2):105-10. PubMed ID: 1358708
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Local therapy of atrophic vaginal conditions with oestriol suppositories.
    Michalas S; Papandrikos A; Koutselini E; Tzingounis V
    J Int Med Res; 1980; 8(5):358-60. PubMed ID: 6998796
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.
    Serati M; Bogani G; Di Dedda MC; Braghiroli A; Uccella S; Cromi A; Ghezzi F
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():48-50. PubMed ID: 26070127
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of long-term local or systemic hormone replacement therapy on post-menopausal mood disturbances. Influences of socio-economic and personality factors.
    Cagnacci A; Neri I; Tarabusi M; Volpe A; Facchinetti F
    Maturitas; 1999 Jan; 31(2):111-6. PubMed ID: 10227003
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Short term oral estriol treatment restores normal premenopausal vaginal flora to elderly women.
    Yoshimura T; Okamura H
    Maturitas; 2001 Sep; 39(3):253-7. PubMed ID: 11574185
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hormonal, metabolic, and endometrial safety of testosterone vaginal cream versus estrogens for the treatment of vulvovaginal atrophy in postmenopausal women: a randomized, placebo-controlled study.
    Fernandes T; Pedro AO; Baccaro LF; Costa-Paiva LH
    Menopause; 2018 Jun; 25(6):641-647. PubMed ID: 29462095
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
    Riis BJ; Christiansen C
    Maturitas; 1984 Jul; 6(1):65-70. PubMed ID: 6381968
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
    Takahashi K; Manabe A; Okada M; Kurioka H; Kanasaki H; Miyazaki K
    Maturitas; 2000 Feb; 34(2):169-77. PubMed ID: 10714912
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of oral estriol succinate therapy on the endometrial morphology in postmenopausal women: the significance of fractionation of the dose.
    Punnonen R; Söderström KO
    Eur J Obstet Gynecol Reprod Biol; 1983 Jan; 14(4):217-24. PubMed ID: 6832445
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting.
    Sánchez-Rovira P; Hirschberg AL; Gil-Gil M; Bermejo-De Las Heras B; Nieto-Magro C
    Oncologist; 2020 Dec; 25(12):e1846-1854. PubMed ID: 32459035
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
    Mattsson LA; Samsioe G
    Acta Obstet Gynecol Scand Suppl; 1985; 130():53-8. PubMed ID: 3859976
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study.
    Manonai J; Theppisai U; Suthutvoravut S; Udomsubpayakul U; Chittacharoen A
    J Obstet Gynaecol Res; 2001 Oct; 27(5):255-60. PubMed ID: 11776507
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy and tolerability of a plant-based, multi-component cream (Ginetrox®) in vulvovaginal disorders of the genitourinary syndrome during menopause.
    Marrai R; Lissi G; Togni S; Maramaldi G; Barbara M; Giacomelli L
    Minerva Ginecol; 2017 Jun; 69(3):245-249. PubMed ID: 28420227
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms.
    van der Linden MC; Gerretsen G; Brandhorst MS; Ooms EC; Kremer CM; Doesburg WH
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):29-33. PubMed ID: 8282140
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Effect of Vaginal Oestriol Cream on Subjective and Objective Symptoms of Stress Urinary Incontinence and Vaginal Atrophy: An International Multi-Centre Pilot Study.
    Weber MA; Lim V; Oryszczyn J; Te West N; Souget J; Jeffery S; Roovers JP; Moore KH
    Gynecol Obstet Invest; 2017; 82(1):15-21. PubMed ID: 26990867
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasma estriol and its conjugates following oral and vaginal administration of estriol to postmenopausal women: correlations with gonadotropin levels.
    Schiff I; Tulchinsky D; Ryan KJ; Kadner S; Levitz M
    Am J Obstet Gynecol; 1980 Dec; 138(8):1137-41. PubMed ID: 6778214
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum concentrations of estriol vary widely after application of vaginal oestriol cream.
    Te West N; Day R; Graham G; Wright M; White C; Popovic G; Moore KH
    Br J Clin Pharmacol; 2021 May; 87(5):2354-2360. PubMed ID: 33129232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.